64 research outputs found
Development of an Agent Based Specialized Multi-Lingual Web Browser for Visually Handicapped
In the modern age everyone needs access to Internet; Visually handicapped are not an exception for that. SPECS (SPEcialized Computer System) is a system developed to give access to the visually handicapped. It has a Braille shell. The user can enter his spoken language. After the selection of the language the user can present his request to the browser through chosen language in Braille. The output generated by the browser is given out as voice message. The effectiveness of this system is measured based on number of requests processed, access speed and precision of the syste
RNA binding proteins in cancer chemotherapeutic drug resistance
Drug resistance has been a major obstacle in the quest for a cancer cure. Many chemotherapeutic treatments fail to overcome chemoresistance, resulting in tumor remission. The exact process that leads to drug resistance in many cancers has not been fully explored or understood. However, the discovery of RNA binding proteins (RBPs) has provided insight into various pathways and post-transcriptional gene modifications involved in drug tolerance. RBPs are evolutionarily conserved proteins, and their abnormal gene expression has been associated with cancer progression. Additionally, RBPs are aberrantly expressed in numerous neoplasms. RBPs have also been implicated in maintaining cancer stemness, epithelial-to-mesenchymal transition, and other processes. In this review, we aim to provide an overview of RBP-mediated mechanisms of drug resistance and their implications in cancer malignancy. We discuss in detail the role of major RBPs and their correlation with noncoding RNAs (ncRNAs) that are associated with the inhibition of chemosensitivity. Understanding and exploring the pathways of RBP-mediated chemoresistance will contribute to the development of improved cancer diagnosis and treatment strategies
Bleomycin and IL-1ÎČâmediated pulmonary fibrosis is IL-17A dependent
Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. To better understand the inflammatory responses that precede and concur with collagen deposition, we used three models of pulmonary fibrosis and identify a critical mechanistic role for IL-17A. After exposure to bleomycin (BLM), but not Schistosoma mansoni eggs, IL-17A produced by CD4+ and γΎ+ T cells induced significant neutrophilia and pulmonary fibrosis. Studies conducted with C57BL/6 il17aâ/â mice confirmed an essential role for IL-17A. Mechanistically, using ifnÎłâ/â, il10â/â, il10â/âil12p40â/â, and il10â/âil17aâ/â mice and TGF-ÎČ blockade, we demonstrate that IL-17Aâdriven fibrosis is suppressed by IL-10 and facilitated by IFN-Îł and IL-12/23p40. BLM-induced IL-17A production was also TGF-ÎČ dependent, and recombinant IL-17Aâmediated fibrosis required TGF-ÎČ, suggesting cooperative roles for IL-17A and TGF-ÎČ in the development of fibrosis. Finally, we show that fibrosis induced by IL-1ÎČ, which mimics BLM-induced fibrosis, is also highly dependent on IL-17A. IL-17A and IL-1ÎČ were also increased in the bronchoalveolar lavage fluid of patients with IPF. Together, these studies identify a critical role for IL-17A in fibrosis, illustrating the potential utility of targeting IL-17A in the treatment of drug and inflammation-induced fibrosis
RNA Binding Protein CUGBP2/CELF2 Mediates Curcumin-Induced Mitotic Catastrophe of Pancreatic Cancer Cells
Curcumin inhibits the growth of pancreatic cancer tumor xenografts in nude mice; however, the mechanism of action is not well understood. It is becoming increasingly clear that RNA binding proteins regulate posttranscriptional gene expression and play a critical role in RNA stability and translation. Here, we have determined that curcumin modulates the expression of RNA binding protein CUGBP2 to inhibit pancreatic cancer growth.In this study, we show that curcumin treated tumor xenografts have a significant reduction in tumor volume and angiogenesis. Curcumin inhibited the proliferation, while inducing G2-M arrest and apoptosis resulting in mitotic catastrophe of various pancreatic cancer cells. This was further confirmed by increased phosphorylation of checkpoint kinase 2 (Chk2) protein coupled with higher levels of nuclear cyclin B1 and Cdc-2. Curcumin increased the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) mRNA, but protein levels were lower. Furthermore, curcumin increased the expression of RNA binding proteins CUGBP2/CELF2 and TIA-1. CUGBP2 binding to COX-2 and VEGF mRNA was also enhanced, thereby increasing mRNA stability, the half-life changing from 30 min to 8 h. On the other hand, silencer-mediated knockdown of CUGBP2 partially restored the expression of COX-2 and VEGF even with curcumin treatment. COX-2 and VEGF mRNA levels were reduced to control levels, while proteins levels were higher.Curcumin inhibits pancreatic tumor growth through mitotic catastrophe by increasing the expression of RNA binding protein CUGBP2, thereby inhibiting the translation of COX-2 and VEGF mRNA. These data suggest that translation inhibition is a novel mechanism of action for curcumin during the therapeutic intervention of pancreatic cancers
Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways
Over the past two decades, cancer stem cells (CSCs) have emerged as an immensely studied and experimental topic, however a wide range of questions concerning the topic still remain unanswered; in particular, the mechanisms underlying the regulation of tumor stem cells and their characteristics. Understanding the cancer stem-cell signaling pathways may pave the way towards a better comprehension of these mechanisms. Signaling pathways such as WNT, STAT, Hedgehog, NOTCH, PI3K/AKT/mTOR, TGF-β, and NF-κB are responsible not only for modulating various features of CSCs but also their microenvironments. Recently, the prominent roles of various non-coding RNAs such as small non-coding RNAs (sncRNAs) and long non-coding RNAs (lncRNAs) in developing and enhancing the tumor phenotypes have been unfolded. This review attempts to shed light on understanding the influence of long non- coding RNAs in the modulation of various CSC-signaling pathways and its impact on the CSCs and tumor properties; highlighting the protagonistic and antagonistic roles of lncRNAs
Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression
<div><p>It is well-known that the conversion of normal colon epithelium to adenoma and then to carcinoma stems from acquired molecular changes in the genome. The genetic basis of colorectal cancer has been elucidated to a certain extent, and much remains to be known about the identity of specific cancer genes that are associated with the advancement of colorectal cancer from one stage to the next. Here in this study we attempted to identify novel cancer genes that could underlie the stage-specific progression and metastasis of colorectal cancer. We conducted a stage-based meta-analysis of the voluminous tumor genome-sequencing data and mined using multiple approaches for novel genes driving the progression to stage-II, stage-III and stage-IV colorectal cancer. The consensus of these driver genes seeded the construction of stage-specific networks, which were then analyzed for the centrality of genes, clustering of subnetworks, and enrichment of gene-ontology processes. Our study identified three novel driver genes as hubs for stage-II progression: <i>DYNC1H1</i>, <i>GRIN2A</i>, <i>GRM1</i>. Four novel driver genes were identified as hubs for stage-III progression: <i>IGF1R</i>, <i>CPS1</i>, <i>SPTA1</i>, <i>DSP</i>. Three novel driver genes were identified as hubs for stage-IV progression: <i>GSK3B</i>, <i>GGT1</i>, <i>EIF2B5</i>. We also identified several non-driver genes that appeared to underscore the progression of colorectal cancer. Our study yielded potential diagnostic biomarkers for colorectal cancer as well as novel stage-specific drug targets for rational intervention. Our methodology is extendable to the analysis of other types of cancer to fill the gaps in our knowledge.</p></div
Moduland decomposition of stage-III network.
<p>Moduland decomposition of stage-III network.</p
Moduland decomposition of stage-II network.
<p>Moduland decomposition of stage-II network.</p
- âŠ